SG Stock MarketDetailed Quotes
8K7 UGHealthcare
- 0.130
- +0.002+1.56%
10min DelayTrading Oct 15 09:03 CST
81.10MMarket Cap-13000P/E (TTM)
0.130High0.130Low100Volume0.130Open0.128Pre Close13.00Turnover0.22552wk High0.00%Turnover Ratio623.83MShares0.08652wk Low-0.01EPS TTM24.36MFloat Cap0.812Historical HighLossP/E (Static)187.39MShs Float0.086Historical Low-0.01EPS LYR0.00%Amplitude--Dividend TTM0.50P/B100Lot Size--Div YieldTTM
Analysis
Price Target
No Data
Heat List
SG
Overall
Symbol
Latest Price
% Chg
No Data
UGHealthcare Stock Forum
Top Glove is confident it has sufficient capacity to meet the anticipated surge in US demand for medical gloves following the imposition of higher tariffs on Chinese imports, which are set to take full effect in Jan 2025.
Top Glove is currently operating at around 60% of its total production capacity, which stands at 60 billion gloves per annum, said executive director Ng Yong Lin during the company's results briefing on Thu.
Ng said Top Glove is "well-positioned" to ramp up ...
The 2025 and 2026 net profit margins of Top Glove Corporation Bhd are projected to grow at 39% and 42%, respectively, as a result of higher sales volume and factory utilisation rate, according to Kenanga Investment Bank Bhd (Kenanga Research).
Unsurprisingly, the glove manufacturer recorded a 75.5% revenue surge year-on-year (YoY) in the last quarter of financial year 2023/242 (4QFY23/24), and its ...
Top Glove Corporation Bhd said on Thu that its net losses narrowed sharply as sales surged, and the world's largest glovemaker by capacity also booked gains from land sale.
Net losses for the three months Aug 31 (4QFY2024) was RM3.57 million, compared to RM461.73 million over the same period last year, Top Glove said in an exchange filing. Revenue for the quarter rose 75% year-on-year to RM835.31 m...
Top Glove's operating metrics are seeing visible signs of recovery despite anticipating short-term headwinds due to an unprecedented weakening of the US dollar.
More importantly, the recently revised US tariff hike on medical gloves from China is poised to catalyse meaningful flowback of demand to Malaysian glove makers, said UOB Kay Hian (UOBKH) Research.
It remains optimistic on Top Glove's prospects over a medium-term horiz...
Top Glove Corporation Bhd, the world's largest glovemaker by volume, will likely report a smaller net loss in its final quarter thanks to higher sales, said RHB Investment Bank.
Core loss will likely come in between RM2 million and RM5 million for the quarter ended Aug 2024 (4QFY2024) versus RM53.5 million in the 3QFY2024 as sales grew 20%, RHB said in an earnings preview. That would bring FY2024's net loss to RM17...
$Top Glove (BVA.SG)$ $Medtecs Intl (546.SG)$ $Riverstone (AP4.SG)$
$Top Glove (BVA.SG)$ $Medtecs Intl (546.SG)$ $Riverstone (AP4.SG)$
Supports around 0.29 and 0.30. May rise ahead of results on Oct 10.
$Medtecs Intl (546.SG)$ $UGHealthcare (8K7.SG)$ $Riverstone (AP4.SG)$
The upcoming increase in US tariffs on China-made gloves provides an opportunity for Malaysian players to increase production, said Top Glove managing director Lim Cheong Guan.
Malaysian players are "able to increase our production" to meet US demand should the tariffs result in a supply vacuum from China, Lim told reporters at a media event on the progress of the glove maker's water m...
No comment yet